Scores2Go
Hepatology · Transplant · Severity

MELD

The Model for End-Stage Liver Disease is an objective, laboratory-based score for assessing short-term prognosis in end-stage liver disease and the primary organ allocation algorithm for liver transplantation.

Kamath et al. 2001 Popularity 88

Overview

MELD was originally developed to predict 90-day mortality after transjugular intrahepatic portosystemic shunt (TIPS) placement. In 2002 it was adopted by UNOS/OPTN as the primary algorithm for prioritising liver transplant allocation in the United States, replacing the Child-Pugh score. It has since been adopted internationally. Scores are clamped between 6 and 40.

Formula

MELD = 3.78 × ln(Bilirubin) + 11.2 × ln(INR) + 9.57 × ln(Creatinine) + 6.43

All values in mg/dL. Result rounded to nearest integer, clamped 6–40.

Clamping Rules

VariableFloorCapSpecial
Bilirubin1.0 mg/dL
INR1.0
Creatinine1.0 mg/dL4.0 mg/dLSet to 4.0 if on dialysis twice/week in past 7 days
MELD total640

Score Interpretation

MELD ScoreSeverityApprox. 90-day Mortality
6–9Mild~1.9 %
10–19Moderate~6–20 %
20–29Severe~20–76 %
30–39Very severe~52–83 %
≥ 40End-stage> 71 %

Clinical Use

Notes on MELD-Na

MELD-Na (MELD-Sodium) incorporates serum sodium to account for the additional mortality risk in hyponatraemic patients with cirrhosis. Formula: MELD-Na = MELD + 1.32 × (137 − Na) − 0.24 × (MELD × (137 − Na)). It has been the standard UNOS allocation algorithm since 2016 and generally provides modestly better discrimination than MELD alone.

Literature

Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470.

Calculate MELD score interactively in the app.

Open in Scores2Go

For research and educational purposes only. Not intended for direct clinical decision-making.